Prediction Case File
YouTubeTracking Live

Revealing My Next Big Bet! (AMD 2.0)

1 extracted signal · 0 resolved · 1 still active

The Patient Investor profile imageThe Patient InvestorIndependent analyst profile
Source published
22 Sept 2026, 18:02 UTC
Recorded by Tahlil Plus
22 Sept 2026, 18:28 UTC
Video preview for Revealing My Next Big Bet! (AMD 2.0)
Source overview

AI-generated source summary

Qualcomm (QCOM) and AMD are analyzed for their investment potential. For Qualcomm, the analysis is based on the company's financial results showing declining revenues in handsets but strong growth in automotive and IoT sectors. Despite the handset revenue decline, the company's non-handset revenue is projected to grow significantly, potentially replacing Apple's product revenue in the future. A key driver for Qualcomm's potential growth is its strategic partnerships, including a recent 10-year, $6 billion deal with Amazon for custom AI data center chips. The company's target EPS is projected to exceed $18 by FY29, suggesting a significant upside from its current trading price. The stock is currently trading around $194.23, with a target price of $360, implying an 85% upside potential over the next 2-3 years. The fail bound is set at $150, below which the bullish thesis would be invalidated. For AMD, the analysis is based on its past performance and future potential, with a previous call for $600. The stock is currently trading around $150. The analysis suggests continued bullish momentum for AMD, with a target of $600 and a fail bound at $130.

AI-generated summary based on the source content.

Live evaluation

Signal outcomes at a glance

Tracking Live
Signals
1
Extracted from this source
Open
1
Still being tracked
Successful
0
Resolved successfully
Failed
0
Resolved unsuccessfully
Other
0
Cancelled, invalid or excluded
Resolved success
0 resolved; open signals omitted
Extracted intelligence

Signals in this source

Case timeline

Evidence and evaluation progress

  1. Original source published

    The analyst published the original source item.

  2. Source recorded by Tahlil Plus

    The public source was preserved as the evidence record for this case.

  3. Market predictions extracted

    1 eligible signal linked to this case.

  4. Source processing completed

    Source analysis and structured extraction completed.

  5. Outcome tracking started

    Tahlil Plus began monitoring the extracted predictions.

  6. Live evaluation in progress

    1 signal remains active.

Analyst snapshot

The Patient Investor

Platform-wide history, separate from this source evaluation.

Reliability
47.2
Tracked signals
341
Historical success
33.9%
View full analyst profile →
Methodology & disclosure

Tahlil Plus independently records and evaluates public market predictions. Extraction may be AI-assisted and results follow the Tahlil Plus methodology. This information is not financial advice.

Continue the evidence trail